“…alpha diversity: no significant difference ( Getachew et al, 2018 ) in vitro (ketamine and propofol mix) | | antimicrobial activity against E.coli, P.aeruginosa and C.albicans. S.aureus not inhibited ( Begec et al, 2013 ) |
in vitro | | dose dependent antimicrobial activity against: S.aureus, S.pyogenes, S.epidermidis, E.faecalis, P.aeruginosa and E.coli S.aureus and S.pyogenes most sensitive ( Gocmen et al, 2008 ) |
in vitro | | antimicrobial activity against Stachybotrys chartarum, Staphylococcus epidermidis and Borrelia burgdorferi ( Torres et al, 2018 ) |
MDMA | | |
|
male rats, MDMA 20 mg/kg, single dose, subcutaneous | inhibits serotonin (SERT), norepinephrine (NET), and dopamine transporters (DAT) | increase in cecal Proteus mirabilis vs placebo, antibiotics reduced MDMA-induced hyperthermia ( Ridge et al, 2019 ) |
SSRI's | | |
|
male mice, escitalopram 10 mg/kg, oral gavage, daily stress (CUMS) | inhibits SERT | responder group: increase in Prevotellaceae UCG-003, and decrease in Ruminococcaceae and Lactobacillaceae vs non-responder group. escitalopram increased alpha-diversity ( Duan et al, 2021 ) |
male mice, amitriptyline (25 mg/kg/d) or fluoxetine (12 mg/kg/d) for 6 weeks, oral gavage, daily stress (CUMS) | | increase in Bacteroidetes and decrease in Firmicutes, increase in Porphyromonadaceae increase in Bacteroidaceae associated with Ami, not Flu increase in Parabacteroides, Butyricimonas , and Alistipes in Ami and Flu alpha diversity increased in Ami and Flu ( Zhang et al, 2021 ) |
male rats, 28 days fluoxetine 10 mg/kg/day, escitalopram 5 mg/kg/day, in drinking water | | fluoxetine inhibited growth of cecal Succinivibrio and Prevotella SSRIs: increase ileal but not colonic permeability in vitro: escitalopram antimicrobial activity against E.coli , but not L.rhamnosus. |
…”